IGHS Grand Rounds on Ebola with Dan Kelly, MD


12:15 to 1:30pm

UCSF Mission Bay Campus 
Mission Hall, room 1401/1402 
550 16th Street, San Francisco, CA  94158
Livestream day of event at tiny.ucsf.edu/IGHSFall2019

Dan Kelly, MD 

Updates on Ebola virus disease amidst a public health emergency in the Congo 

Join IGHS for Grand Rounds featuring Dan Kelly in conversation with George Rutherford, executive director of IGHS Global Strategic Information, and IGHS PhD candidate Mohamed Bailor Barrie. Dr. Kelly will discuss the ongoing Ebola outbreak in the Democratic Republic of the Congo and scientific advances since the 2013-2016 outbreak in West Africa. Dan will also present his Ebola research, which focuses on prevention and care, and situate its potential impact in relation to the ongoing outbreak. 

After graduating from Princeton University, Dan Kelly, MD, MPH, went to Albert Einstein College of Medicine, where he pursued a Global Health Fellowship after his third year. In Sierra Leone, a local doctor and he were inspired to start Wellbody Alliance, a health and human rights non-profit organization that provides high-quality healthcare to the rural poor. After internal medicine residency and with a Fulbright scholarship, Dan conducted HIV research in Sierra Leone while building the community health work of Wellbody Alliance to care for the half million people living in rural Kono district. Dan was an infectious disease fellow at University of California, San Francisco, and an MPH student at University of California, Berkeley, when Ebola struck Sierra Leone. After a close friend died of Ebola in August 2014, Dan decided to take a leave of absence from fellowship training and the MPH to take a full-time leadership role in the Ebola response. Dan reached out to his long-time mentor Paul Farmer and established a coalition with Partners In Health in Sierra Leone. Dan spent eight months on the ground in Sierra Leone during the Ebola epidemic and led multiple frontiers of work, ranging from Ebola care to clinical trials of innovative Ebola diagnostics, and integrated Wellbody Alliance into Partners In Health. Dan returned to UCSF and UCB and finished his infectious disease fellowship and MPH. Dan continues to conduct Ebola research in Sierra Leone and Liberia. He employs sero-epidemiology, transmission mapping and modeling techniques, and clinical research cohorts to investigate asymptomatic Ebola virus infection and mild illness. Dan has published on Ebola in New England Journal of Medicine, Nature, and The Lancet.